Our Pharmaceutical Development Facilities
To meet all your clinical trial needs, we provide a range of solid oral dose development and manufacturing services from 3 state-of-the-art Pharmaceutical Development facilities located across 2 campuses – Craigavon, UK and Charnwood, UK.
Whether your requirements are for First in Human supplies, later phase development or manufacture of registration batches; with both non-GMP and GMP facilities, flexible and efficient solutions are guaranteed.
Across both campuses, our manufacturing operations have been built and designed around the concept of enabling scalability, ensuring we have superior integration of all solid oral dosage manufacturing technologies. From non-GMP to GMP development, to clinical supply, through to commercialization, we ensure ease of scale-up and scientific continuity.
|Non-GMP drug product development (up to 5kg batch size)||•|
|GMP drug product development (up to 100kg batch size)||•||•|
|High potency processing||•||•|
|Analytical development, validation, stability and micro||•||•|
|GMP footprint available for client supported investments||•|
|Commercial manufacturing (up to 2500kg batch size)||•||•|
Available GMP Floor Space
Our world-class Charnwood campus facilities are extensive and currently have over 1,500m2 of readily available GMP floor space that can be customized to suit the specific needs of our client partners.
These flexible GMP modules are scalable in size from 22m2 to 100m2 and are suitable for pharmaceutical development, GMP manufacturing, drug product packaging or kit assembly. With the appropriate technology investments, they could be utilized for many dosage forms and processes.
If you are currently facing the build or buy decision for your proprietary technology to meet increasing patient needs, why not leverage Almac’s technical expertise for delivering complex capital projects and discover how we can provide a bespoke, timely solution. Contact us directly to learn more.